Literature DB >> 18787396

Knockdown of B-Raf impairs spindle formation and the mitotic checkpoint in human somatic cells.

M K Borysova1, Y Cui, M Snyder, T M Guadagno.   

Abstract

It is well established that B-Raf signaling through the MAP kinase (ERK) pathways plays a prominent role in regulating cell proliferation but how it does this is not completely understood. Here, we show that B-Raf serves a physiological role during mitosis in human somatic cells. Knockdown of B-Raf using short interfering RNA (siRNA) resulted in pleiotropic spindle abnormalities and misaligned chromosomes in over 80% of the mitotic cells analyzed. A second B-Raf siRNA gave similar results suggesting these effects are specific to downregulating B-Raf protein. In agreement with these findings, a portion of B-Raf was detected at the spindle structures including the spindle poles and kinetochores. Knockdown of C-Raf (Raf-1) had no detectable effects on spindle formation or chromosome alignment. Activation of the spindle assembly checkpoint was found to be dependent on B-Raf as evident by the inability of checkpoint proteins Bub1 and Mad2 to localize to unattached kinetochores in HeLa cells treated with B-Raf siRNA. Consistent with this, live-cell imaging microscopy showed that B-Raf-depleted cells exited mitosis earlier than control non-depleted cells. Finally, we provide evidence that B-Raf signaling promotes phosphorylation and kinetochore localization of the mitotic checkpoint kinase Mps1. Blocking B-Raf expression, ERK activity, or phosphorylation at Ser-821 residue perturbed Mps1 localization at unattached kinetochores. Thus, our data implicates a mitotic role for B-Raf in regulating spindle formation and the spindle checkpoint in human somatic cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787396     DOI: 10.4161/cc.7.18.6678

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  12 in total

1.  c-Src but not Fyn promotes proper spindle orientation in early prometaphase.

Authors:  Yuji Nakayama; Yuki Matsui; Yumi Takeda; Mai Okamoto; Kohei Abe; Yasunori Fukumoto; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

Review 2.  A look into centrosome abnormalities in colon cancer cells, how they arise and how they might be targeted therapeutically.

Authors:  Lauren E Harrison; Marina Bleiler; Charles Giardina
Journal:  Biochem Pharmacol       Date:  2017-11-09       Impact factor: 5.858

3.  The interaction of Epac1 and Ran promotes Rap1 activation at the nuclear envelope.

Authors:  Chang Liu; Maho Takahashi; Yanping Li; Tara J Dillon; Stefanie Kaech; Philip J S Stork
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

Review 4.  The MPS1 family of protein kinases.

Authors:  Xuedong Liu; Mark Winey
Journal:  Annu Rev Biochem       Date:  2012-04-05       Impact factor: 23.643

5.  Type 10 soluble adenylyl cyclase is overexpressed in prostate carcinoma and controls proliferation of prostate cancer cells.

Authors:  Jan-Paul Flacke; Hanna Flacke; Avinash Appukuttan; Rein-Jüri Palisaar; Joachim Noldus; Brian D Robinson; H Peter Reusch; Jonathan H Zippin; Yury Ladilov
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

6.  CAML loss causes anaphase failure and chromosome missegregation.

Authors:  Yu Liu; Liviu Malureanu; Karthik B Jeganathan; David Dinh Tran; Lonn D Lindquist; Jan M van Deursen; Richard J Bram
Journal:  Cell Cycle       Date:  2009-03-26       Impact factor: 4.534

7.  Mitogen-activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere-associated protein E inhibition.

Authors:  Patrick A Mayes; Yan Y Degenhardt; Andrew Wood; Yana Toporovskya; Sharon J Diskin; Elizabeth Haglund; Christopher Moy; Richard Wooster; John M Maris
Journal:  Int J Cancer       Date:  2012-09-28       Impact factor: 7.396

8.  High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888.

Authors:  Susan K Lyman; Suzanne C Crawley; Ruoyu Gong; Joanne I Adamkewicz; Garth McGrath; Jason Y Chew; Jennifer Choi; Charles R Holst; Leanne H Goon; Scott A Detmer; Jana Vaclavikova; Mary E Gerritsen; Robert A Blake
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

9.  A MEK-independent role for CRAF in mitosis and tumor progression.

Authors:  Ainhoa Mielgo; Laetitia Seguin; Miller Huang; Maria Fernanda Camargo; Sudarshan Anand; Aleksandra Franovic; Sara M Weis; Sunil J Advani; Eric A Murphy; David A Cheresh
Journal:  Nat Med       Date:  2011-11-13       Impact factor: 53.440

Review 10.  Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health.

Authors:  William H Chappell; Linda S Steelman; Jacquelyn M Long; Ruth C Kempf; Stephen L Abrams; Richard A Franklin; Jörg Bäsecke; Franca Stivala; Marco Donia; Paolo Fagone; Graziella Malaponte; Maria C Mazzarino; Ferdinando Nicoletti; Massimo Libra; Danijela Maksimovic-Ivanic; Sanja Mijatovic; Giuseppe Montalto; Melchiorre Cervello; Piotr Laidler; Michele Milella; Agostino Tafuri; Antonio Bonati; Camilla Evangelisti; Lucio Cocco; Alberto M Martelli; James A McCubrey
Journal:  Oncotarget       Date:  2011-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.